Tech Company Financing Transactions
Quotient ADHD System Funding Round
Quotient ADHD System, based in Westford, secured $8.5 million from Sevin Rosen Funds and Tullis Health Investors.
Transaction Overview
Company Name
Announced On
2/2/2007
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Sevin Rosen Funds (David McLean)
Tullis Health Investors (Timothy Buono)
Proceeds Purpose
The funds raised in this financing will allow
the company to commercialize its lead product, the MMAT/ADHD� System, which
BioBDx anticipates launching in the U.S. in 2008.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
239 Littleton Rd. 6a
Westford, MA 01886
USA
Westford, MA 01886
USA
Phone
Website
Email Address
Overview
Clinical Evaluations Can Now Include Objective, Research Based Data on the 3 Core ADHD Symptom
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Calvin Sumner
VP - Marketing
Carrie Mulherin
VP - Product Management
Ken Hoadley
Browse more venture capital transactions:
Prev: 2/2/2007: A&G Pharmaceutical venture capital transaction
Next: 2/5/2007: Trigence venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs